Free Trial
NASDAQ:NMRD

Nemaura Medical (NMRD) Stock Price, News & Analysis

Nemaura Medical logo
$0.0001 0.00 (-50.00%)
As of 07/31/2025 09:46 AM Eastern

About Nemaura Medical Stock (NASDAQ:NMRD)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.00
$0.05
Volume
400 shs
Average Volume
8,341 shs
Market Capitalization
$4.04 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nemaura Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

NMRD MarketRank™: 

Nemaura Medical scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Nemaura Medical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nemaura Medical is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Nemaura Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Nemaura Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Nemaura Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Nemaura Medical does not currently pay a dividend.

  • Dividend Growth

    Nemaura Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the outstanding shares of Nemaura Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Nemaura Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nemaura Medical this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nemaura Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.41% of the stock of Nemaura Medical is held by institutions.

  • Read more about Nemaura Medical's insider trading history.
Receive NMRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter.

NMRD Stock News Headlines

NMRD Nemaura Medical Inc.
One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
Nemaura Medical Inc (NMRD)
NXNN Nexeon Medsystems Inc
See More Headlines

NMRD Stock Analysis - Frequently Asked Questions

Nemaura Medical's stock was trading at $0.0001 at the beginning of the year. Since then, NMRD shares have increased by 0.0% and is now trading at $0.0001.

Nemaura Medical Inc. (NASDAQ:NMRD) posted its quarterly earnings results on Monday, February, 12th. The company reported ($0.12) EPS for the quarter.

Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nemaura Medical investors own include Ford Motor (F), Pfizer (PFE), Meta Platforms (META), Exxon Mobil (XOM), Agile Therapeutics (AGRX) and Tesla (TSLA).

Company Calendar

Last Earnings
2/12/2024
Today
8/01/2025
Next Earnings (Estimated)
9/29/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NMRD
CIK
1602078
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$3.02 thousand
Price / Sales
1.34
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.41) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
40,352,000
Free Float
24,042,000
Market Cap
$4.04 thousand
Optionable
No Data
Beta
0.50
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:NMRD) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners